BackAkums Drugs & Pharmaceuticals Overview

Akums Drugs & Pharmaceuticals Intangible Assets

Track Akums Drugs & Pharmaceuticals's intangible assets ($62M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$62.09M
↓ 25.22% YoYΔ $-20.94M vs prior year quarter

Peer trimmed avg / median

Loading

Akums Drugs & Pharmaceuticals Intangible Assets History

Loading

Akums Drugs & Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

Akums Drugs & Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Akums Drugs & Pharmaceuticals (AKUMS.NS) FAQ

As of the most recent data (March 2026), AKUMS.NS shows a intangible assets of $62M. That compares with $83M in the prior-year period — down 25.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AKUMS.NS's intangible assets is now $62M (was $83M) — a 25.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Akums Drugs & Pharmaceuticals is outperforming or lagging.

Tracking AKUMS.NS's intangible assets over time shows whether Akums Drugs & Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $62M That compares with $83M in the prior-year period — down 25.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Akums Drugs & Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $62M) with ownership activity and broader fundamentals.